Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Platero

Showing results (341-350 of 355) with videos related to

Pageof 36
Sort By:
Human Vaccines & Immunotherapeutics|May 13, 2024
Assessment of effectiveness and impact of universal prophylaxis with nirsevimab for prevention of hospitalizations due to respiratory syncytial virus in infants. The NIRSE-GAL study protocolNarmeen Mallah, Sonia Ares-Gómez, Jacobo Pardo-Seco, et al.
Journal of Clinical Medicine|July 2, 2021
Exercise Ventilatory Inefficiency in Post-COVID-19 Syndrome: Insights from a Prospective EvaluationÁlvaro Aparisi, Cristina Ybarra-Falcón, Mario García-Gómez, et al.
Movement Disorders Clinical Practice|January 10, 2026
Voice and Speech in Atypical Parkinsonian DisordersFederico Rodriguez-Porcel, Farwa Ali, Michiko Bruno, et al.
European Journal of Pediatrics|May 2, 2025
Respiratory syncytial virus-related lower respiratory tract infection hospitalizations in infants receiving nirsevimab in Galicia (Spain): the NIRSE-GAL studyAngela Manzanares, Jacobo Pardo-Seco, Irene Rivero-Calle, et al.
Nature|March 1, 2019
Author Correction: Mitochondrial replacement in human oocytes carrying pathogenic mitochondrial DNA mutationsEunju Kang, Jun Wu, Nuria Marti Gutierrez, et al.
Nature|December 6, 2016
Mitochondrial replacement in human oocytes carrying pathogenic mitochondrial DNA mutationsEunju Kang, Jun Wu, Nuria Marti Gutierrez, et al.
Molecular Cancer Therapeutics|March 26, 2017
Discovery and Pharmacological Characterization of JNJ-42756493 (Erdafitinib), a Functionally Selective Small-Molecule FGFR Family InhibitorTimothy P S Perera, Eleonora Jovcheva, Laurence Mevellec, et al.
The Lancet. Infectious Diseases|May 3, 2024
Effectiveness and impact of universal prophylaxis with nirsevimab in infants against hospitalisation for respiratory syncytial virus in Galicia, Spain: initial results of a population-based longitudinal studySonia Ares-Gómez, Narmeen Mallah, María-Isolina Santiago-Pérez, et al.
Mitochondrial DNA. Part B, Resources|January 21, 2021
The mitochondrial genome of the planorbid snail <i>Planorbella duryi</i>Jonathan H Schultz, Lauren M Bansbach, Jarrett A Bremmer, et al.
The Lancet. Infectious Diseases|January 15, 2026
Impact of universal nirsevimab prophylaxis in infants on hospital and primary care outcomes across two respiratory syncytial virus seasons in Galicia, Spain (NIRSE-GAL): a population-based prospective observational studyJosefina L Razzini, Iago Giné-Vázquez, Jing Jin, et al.
Pageof 36

Showing results (341-350 of 355) with videos related to

Sort By:
Pageof 36
Human Vaccines & Immunotherapeutics|May 13, 2024
Assessment of effectiveness and impact of universal prophylaxis with nirsevimab for prevention of hospitalizations due to respiratory syncytial virus in infants. The NIRSE-GAL study protocolNarmeen Mallah, Sonia Ares-Gómez, Jacobo Pardo-Seco, et al.
Journal of Clinical Medicine|July 2, 2021
Exercise Ventilatory Inefficiency in Post-COVID-19 Syndrome: Insights from a Prospective EvaluationÁlvaro Aparisi, Cristina Ybarra-Falcón, Mario García-Gómez, et al.
Movement Disorders Clinical Practice|January 10, 2026
Voice and Speech in Atypical Parkinsonian DisordersFederico Rodriguez-Porcel, Farwa Ali, Michiko Bruno, et al.
European Journal of Pediatrics|May 2, 2025
Respiratory syncytial virus-related lower respiratory tract infection hospitalizations in infants receiving nirsevimab in Galicia (Spain): the NIRSE-GAL studyAngela Manzanares, Jacobo Pardo-Seco, Irene Rivero-Calle, et al.
Nature|March 1, 2019
Author Correction: Mitochondrial replacement in human oocytes carrying pathogenic mitochondrial DNA mutationsEunju Kang, Jun Wu, Nuria Marti Gutierrez, et al.
Nature|December 6, 2016
Mitochondrial replacement in human oocytes carrying pathogenic mitochondrial DNA mutationsEunju Kang, Jun Wu, Nuria Marti Gutierrez, et al.
Molecular Cancer Therapeutics|March 26, 2017
Discovery and Pharmacological Characterization of JNJ-42756493 (Erdafitinib), a Functionally Selective Small-Molecule FGFR Family InhibitorTimothy P S Perera, Eleonora Jovcheva, Laurence Mevellec, et al.
The Lancet. Infectious Diseases|May 3, 2024
Effectiveness and impact of universal prophylaxis with nirsevimab in infants against hospitalisation for respiratory syncytial virus in Galicia, Spain: initial results of a population-based longitudinal studySonia Ares-Gómez, Narmeen Mallah, María-Isolina Santiago-Pérez, et al.
Mitochondrial DNA. Part B, Resources|January 21, 2021
The mitochondrial genome of the planorbid snail <i>Planorbella duryi</i>Jonathan H Schultz, Lauren M Bansbach, Jarrett A Bremmer, et al.
The Lancet. Infectious Diseases|January 15, 2026
Impact of universal nirsevimab prophylaxis in infants on hospital and primary care outcomes across two respiratory syncytial virus seasons in Galicia, Spain (NIRSE-GAL): a population-based prospective observational studyJosefina L Razzini, Iago Giné-Vázquez, Jing Jin, et al.
Pageof 36